|
Resolution: standard / high Figure 2.
Survival in 26 MAP patients, according to CD8+ status and granzyme B+ status. high versus low, median, number of TILs as cut off point. Log rank; P = 0.15 (CD8+) and Log rank; P = 0.2 (granzyme B+).
Nielsen et al. BMC Cancer 2009 9:184 doi:10.1186/1471-2407-9-184 |
